FDA Adverse Event Malfunction Summary report: N

REMUNITY PUMP FOR REMODULIN (TREPROSTINIL) INJECTION

MDR report key: 24719305 · Received March 30, 2026

Report

Report Number
3016798778-2026-00072
Event Type
Malfunction
Date Received
March 30, 2026
Date of Event
February 26, 2026
Report Date
March 27, 2026
Manufacturer
MILLYARD ADVANCED MEDICAL PRODUCTS, LLC
Product Code
QJY
UDI-DI
00850017421035
PMA / PMN Number
K202690
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

EFFORTS TO OBTAIN ADDITIONAL INFORMATION FROM ACCREDO HEALTH GROUP, INC. ARE ONGOING. ANY NEW INFORMATION RELEVANT TO THE EVENT WILL BE PROVIDED IN A FOLLOW-UP REPORT. AT THIS TIME, NO COMPONENTS OR FURTHER INFORMATION HAVE BEEN MADE AVAILABLE TO MILLYARD ADVANCED MEDICAL PRODUCTS, LLC FOR ADDITIONAL INVESTIGATION.

Description of Event or Problem · 0

AN INITIAL EVENT NOTIFICATION WAS RECEIVED BY UNITED THERAPEUTICS DRUG SAFETY ON 27-FEB-2026 AND FORWARDED TO MILLYARD ADVANCED MEDICAL PRODUCTS, LLC ON 28-FEB-2026. IT WAS REPORTED THAT THE PATIENT RECEIVED CASSETTE DEPLETED AND CASSETTE PROBLEM ALARMS WHILE USING REMUNITY PUMPS, (B)(6). TROUBLESHOOTING EFFORTS WERE UNSUCCESSFUL. THE PATIENT WAS SUBSEQUENTLY HOSPITALIZED ON (B)(6) 2026 AND PLACED ON INTRAVENOUS REMODULIN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
783437 REMUNITY PUMP FOR REMODULIN (TREPROSTINIL) INJECTION INFUSION PUMP QJY MILLYARD ADVANCED MEDICAL PRODUCTS, LLC DKPI-11042-001; DKPI-11036-001 00850017421035

Patients

Seq Age Sex Outcome Treatment
1 43 YR Male Hospitalization ALBUTEROL SULFATE HFA.| AMBRISENTAN.| AMIODARONE HCL.| ATORVASTATIN CALCIUM.| BREO ELLIPTA.| BUMETANIDE.| C-PAP.| CHOLECALCIFEROL CRYSTALS.| ELIQUIS.| GABAPENTIN.| LETAIRIS.| METFORMIN HCL.| OMEPRAZOLE.| SILDENAFIL CITRATE.| SOD CHLORIDE.| TYLENOL ARTHRITIS.| WINREVAIR.